IL6 and cancer: These pathways activate the pro-inflammatory cytokines interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α), which function as cytoprotective agents by reducing the expression of molecules associated with cancer and inhibiting the development of liver tumors related to steatosis [94].